News und Analysen
House, Senate Pass $18B Texas Property Tax Relief Bill: How it Benefits You
Ending the month-long stalemate, the Texas House on Thursday approved the landmark property tax relief bill that was passed by the Senate a day before. The $18 billion Texas property tax relief
Pfizer Just Invested $25 Million In This Biotech
Key Points
- Caribou surged 45% yesterday after news broke that Pfizer invested $25 million.
- The investment by Pfizer signals a strong confidence in Caribou’s pipeline and lead candidates.
Tax Software Specialist Vertex In Buy Zone After Base Breakout
Key Points
- Vertex is currently in the buy range after clearing a seven-week consolidation on June 7.
- Trading volume was more than double the average as the stock cleared resistance above
Anhaltend starke Cresemba® (Isavuconazol)-Verkaufszahlen von Pfizer lösen Umsatzmeilensteinzahlungen in Höhe von USD 26 Mio. an Basilea aus
Ad hoc-Mitteilung gemäss Art. 53 KR
Allschwil, 08. Juni 2023
Basilea Pharmaceutica AG, Allschwil (SIX: BSLN), ein biopharmazeutisches Unternehmen mit bereits vermarkteten Produkten und dem Ziel
Lawmakers Sign Off On Law Enforcement Oversight Reforms
Sunset legislation aims to make fundamental changes to operations at the Texas Commission on Law Enforcement, which oversees licensure of law enforcement.
Building Public Confidence In Law
Vertex Labs Acquires Digimental Studio For Us$12 Million
LONDON, UNITED KINGDOM, May 23rd, 2023, Chainwire
Vertex Labs (Vertexlabs.uk), the brain behind the Caduceus metaverse protocol, Vertex Network and 3D metaverse platform, LightCycle, has acquired
Zoetis Declares New Dividend, Hinting At Undervaluation
Key Points
- JAB has announced its plans to acquire Pumpkin, a pet insurance platform launched by Zoetis, which is still a minority holder.
- As Zoetis undertakes its plans for sustainable
Chinook Therapeutics Inc: Too Little, Too Late – Muddy Waters
Muddy Waters is short Chinook Therapeutics Inc (NASDAQ:KDNY) because we believe it is highly unlikely that atrasentan, its lead product candidate, will be approved by the FDA. We conclude that
Amgen – Trendumkehr möglich
High-Yield Pfizer Falls Off The COVID Cliff, And Survives
Key Points
- Pfizer’s Q1 results top expectations on strength in COVID sales.
- Ex-COVID sales grew by 5% and are expected to accelerate in the 2nd half.
- The stock yields more than 4% and
BioNTech veröffentlicht am 8. Mai 2023 Ergebnisse des ersten Quartals und informiert zum operativen Fortschritt
MAINZ, Deutschland, 24. April 2023 (GLOBE NEWSWIRE) – BioNTech SE (Nasdaq: BNTX, „BioNTech” oder „das Unternehmen“) wird am Montag, den 8. Mai 2023, die Ergebnisse des ersten Quartals 2023